Compounding Chemotherapy Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19932377

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19932377

Table of Contents
Description

The global Compounding Chemotherapy market is projected to reach $696.34 million by 2028, expanding at a compound annual growth rate (CAGR) of 6.66% from 2021 to 2028. This growth is driven by various macro and microeconomic factors, including the increasing scarcity of opioids.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA]))
By Technology (With Robotic Arms, Without Robotic Arms)
By Dose (Chemotherapeutic, Non-Chemotherapeutics)
By Delivery Method (Gravimetric Automated Compounding Device (weight-based), Volumetric Automated Compounding Device (volume-based))

Key players

Braun Melsungen AG
Pfizer Inc.
Baxter
Grifols SA
The Metrix Company
Added Pharma
Equashield, Millers Pharmacy
Comecer S.P.A.
Omnicell
Loccioni

Chapter 1. Executive Summary
Chapter 2. Scope of The Study: 2.1. Market Definition; 2.2. Scope of The Study; 2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends: 4.1. Supply/ Value Chain Analysis; 4.2. Porter’s Five Forces Analysis; 4.2.1. Threat of New Entrants; 4.2.2. Bargaining Power of Buyers; 4.2.3. Bargaining Power of Suppliers; 4.2.4. Threat of Substitutes; 4.2.5. Industry Rivalry; 4.3. Impact of COVID-19 on Compounding Chemotherapy Market; 4.3.1. Impact on Market Size; 4.3.2. Delivery Methodr Trend, Preferences and Budget Impact; 4.3.3. Regulatory Framework/Government Policies; 4.3.4. Key Players Strategy to Tackle Negative Impact; 4.3.5. Opportunity Window
Chapter 5. Market Dynamics: 5.1. Introduction; 5.2. DRO Analysis; 5.2.1. Drivers; 5.2.2. Restraints; 5.2.3. Opportunities
Chapter 6. Global Compounding Chemotherapy Market, By Compounding Type: 6.1. Introduction; 6.2. Pharmaceutical Ingredient Alteration (PIA); 6.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM); 6.4. Pharmaceutical Dosage Alteration (PDA])
Chapter 7. Global Compounding Chemotherapy Market, By Technology: 7.1. Introduction; 7.2. With Robotic Arms; 7.3. Without Robotic Arms
Chapter 8. Global Compounding Chemotherapy Market, By Dose: 8.1. Introduction; 8.2. Chemotherapeutic; 8.3. Non-Chemotherapeutics
Chapter 9. Global Compounding Chemotherapy Market, By Delivery Method: 9.1. Introduction; 9.2. Gravimetric Automated Compounding Device (weight-based); 9.3. Volumetric Automated Compounding Device (volume-based)
Chapter 10. Global Compounding Chemotherapy Market, By Region: 10.1. Introduction; 10.2. North America; 10.2.1. Introduction; 10.2.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.2.3. Market Size and Forecast, By Country, 2020 - 2028; 10.2.4. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.2.5. Market Size and Forecast, By Technology, 2020 - 2028; 10.2.6. Market Size and Forecast, By Dose, 2020 – 2028; 10.2.7. Market Size and Forecast, By Delivery Methodr, 2020 – 2028; 10.2.8. US; 10.2.8.1. Introduction; 10.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.2.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.2.8.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.2.8.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.2.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.2.9. Canada; 10.2.9.1. Introduction; 10.2.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.2.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.2.9.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.2.9.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.2.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.3. Europe; 10.3.1. Introduction; 10.3.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.3. Market Size and Forecast, By Country, 2020 - 2028; 10.3.4. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.3.5. Market Size and Forecast, By Technology, 2020 - 2028; 10.3.6. Market Size and Forecast, By Dose, 2020 – 2028; 10.3.7. Market Size and Forecast, By Delivery Methodr, 2020 – 2028; 10.3.8. Germany; 10.3.8.1. Introduction; 10.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.3.8.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.3.8.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.3.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.3.9. France; 10.3.9.1. Introduction; 10.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.3.9.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.3.9.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.3.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.3.10. UK; 10.3.10.1. Introduction; 10.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.10.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.3.10.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.3.10.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.3.10.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.3.11. Italy; 10.3.11.1. Introduction; 10.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.11.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.3.11.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.3.11.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.3.11.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.3.12. Rest of Europe; 10.3.12.1. Introduction; 10.3.12.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.3.12.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.3.12.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.3.12.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.3.12.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.4. Asia-Pacific; 10.4.1. Introduction; 10.4.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.3. Market Size and Forecast, By Country, 2020 - 2028; 10.4.4. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.4.5. Market Size and Forecast, By Technology, 2020 - 2028; 10.4.6. Market Size and Forecast, By Dose, 2020 – 2028; 10.4.7. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.4.8. China; 10.4.8.1. Introduction; 10.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.4.8.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.4.8.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.4.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.4.9. India; 10.4.9.1. Introduction; 10.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.4.9.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.4.9.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.4.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.4.10. Japan; 10.4.10.1. Introduction; 10.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.10.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.4.10.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.4.10.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.4.10.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.4.11. South Korea; 10.4.11.1. Introduction; 10.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.11.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.4.11.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.4.11.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.4.11.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.4.12. Rest of Asia-Pacific; 10.4.12.1. Introduction; 10.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.4.12.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.4.12.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.4.12.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.4.12.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.5. Rest of The World (RoW); 10.5.1. Introduction; 10.5.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.5.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.5.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.5.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.5.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.5.7. Market Size and Forecast, By Region, 2020 - 2028; 10.5.8. South America; 10.5.8.1. Introduction; 10.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.5.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.5.8.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.5.8.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.5.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028; 10.5.9. Middle East & Africa; 10.5.9.1. Introduction; 10.5.9.2. Driving Factors, Opportunity Analyzed and Key Trends; 10.5.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028; 10.5.9.4. Market Size and Forecast, By Technology, 2020 - 2028; 10.5.9.5. Market Size and Forecast, By Dose, 2020 – 2028; 10.5.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
Chapter 11. Competitive Landscape: 11.1. Introduction; 11.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
Chapter 12. Company Profiles: 12.1. Braun Melsungen AG; 12.1.1. Business Overview; 12.1.2. Financial Analysis; 12.1.3. Product Portfolio; 12.1.4. Recent Development and Strategies Adopted; 12.1.5. SWOT Analysis; 12.2. Pfizer Inc.; 12.2.1. Business Overview; 12.2.2. Financial Analysis; 12.2.3. Product Portfolio; 12.2.4. Recent Development and Strategies Adopted; 12.2.5. SWOT Analysis; 12.3. Baxter; 12.3.1. Business Overview; 12.3.2. Financial Analysis; 12.3.3. Product Portfolio; 12.3.4. Recent Development and Strategies Adopted; 12.3.5. SWOT Analysis; 12.4. Grifols SA; 12.4.1. Business Overview; 12.4.2. Financial Analysis; 12.4.3. Product Portfolio; 12.4.4. Recent Development and Strategies Adopted; 12.4.5. SWOT Analysis; 12.5. The Metrix Company; 12.5.1. Business Overview; 12.5.2. Financial Analysis; 12.5.3. Product Portfolio; 12.5.4. Recent Development and Strategies Adopted; 12.5.5. SWOT Analysis; 12.6. Added Pharma; 12.6.1. Business Overview; 12.6.2. Financial Analysis; 12.6.3. Product Portfolio; 12.6.4. Recent Development and Strategies Adopted; 12.6.5. SWOT Analysis; 12.7. Equashield, Millers Pharmacy; 12.7.1. Business Overview; 12.7.2. Financial Analysis; 12.7.3. Product Portfolio; 12.7.4. Recent Development and Strategies Adopted; 12.7.5. SWOT Analysis; 12.8. Comecer S.P.A.; 12.8.1. Business Overview; 12.8.2. Financial Analysis; 12.8.3. Product Portfolio; 12.8.4. Recent Development and Strategies Adopted; 12.8.5. SWOT Analysis; 12.9. Omnicell; 12.9.1. Business Overview; 12.9.2. Financial Analysis; 12.9.3. Product Portfolio; 12.9.4. Recent Development and Strategies Adopted; 12.9.5. SWOT Analysis; 12.10. Loccioni; 12.10.1. Business Overview; 12.10.2. Financial Analysis; 12.10.3. Product Portfolio; 12.10.4. Recent Development and Strategies Adopted; 12.10.5. SWOT Analysis
Chapter 13. Key Takeaways